共 50 条
- [31] The dual role of empagliflozin: Cardio renal protection in T2DM patients ANNALS OF MEDICINE AND SURGERY, 2022, 81
- [39] Emerging combinatorial hormone therapies for the treatment of obesity and T2DM Nature Reviews Endocrinology, 2013, 9 : 425 - 433
- [40] PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD Nature Reviews Endocrinology, 2017, 13 : 36 - 49